ARTL News and Press, Artelo Biosciences Inc. From 02/08/21

Artelo Biosciences (ARTL) traded 3.4% higher premarket after exercising a portion of its warrants from its October 2020 financing.Existing investors agreed to exercise warrants for net proceeds of ~$3M."The proceeds from the exercise of these warrants strengthen our balanc...

LA JOLLA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage biopharmaceutical company developing therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced the exercise of a p...

Gainers: Cassava Sciences (SAVA) +126%.Ocugen (OCGN) +75%.American Resources (AREC) +51%.Lizhi (LIZI) +46%.Aeterna Zentaris (AEZS) +35%.Moleculin Biotech (MBRX) +35%.Holicity (HOL) +35%.Prothena (PRTA) +32%.TETRA Technologies (TTI) +32%.Artelo Biosciences (ARTL) +29%.Losers: Ga...

Gainers: Ocugen OCGN +76%, Cassava Sciences SAVA +65%, Moleculin Biotech MBRX +47%, Artelo Biosciences (ARTL) +28%, Atossa Therapeutics (ATOS) +20%.Losers: Immunovant IMVT -39%, Dynavax Technologies (DVAX) -19%, Retractable Technolog...

LA JOLLA, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL ) today embarks on a collaboration with researchers from Trinity College Dublin to investigate pre-clinical models of human cancer cachexia, a wasting syndrome that affects up to 8...

Artelo Biosciences (ARTL) +78%.Moleculin Biotech (MBRX) +49% on announcing 100% survival achieved in Osteosarcoma Lung Metastases Animal Model.DURECT (DRRX) +42% after FDA approval for Posimir.Holicity (HOLUU) +38% on plan to take rocket maker Astra public.Tiziana Life Sciences...

LA JOLLA, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage biopharmaceutical company developing therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced that it will be pre...

Artelo Biosciences (ARTL): Q1 GAAP EPS of -$0.14 misses by $0.04.Cash and cash equivalents of ~$7.39M.Shares are up 1% PM.Press Release For further details see: Artelo Biosciences EPS misses by $0.04

Received Clinical Trial Authorization to Commence Cancer Appetite Recovery Phase I/II Clinical Study of ART27.13 in UK Awarded Mitacs Accelerate Grant LA JOLLA, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL ) , a c...

Lion Group Holding (LGHL) +142%.SCWorx (WORX) +55%.Future FinTech Group (FTFT) +41%.Optical Cable Corporation (OCC) +29%.ZW Data Action Technologies (CNET) +29%.Jaguar Health (JAGX) +25%.Merus N.V. (MRUS) +24% after FDA grants Fast Track designation to it's Zenocutuzumab.Ideanomics ...